Evaluation of Baseline Factors on Progression in a Large Phase-2 Clinical Trial for Geographic Atrophy (FILLY Study)

被引：0
|
作者：
Steinle, Nathan [1 ]
Hamdani, Mohamed [1 ]
机构：
[1] Calif Retina Consultants, Arroyo Grande, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
973
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Assessment of Progression of Geographic Atrophy in the FILLY Study
    Chiang, Allen
    Lally, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [2] Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan
    Steinle, Nathan C.
    Pearce, Ian
    Mones, Jordi
    Metlapally, Ravi
    Saroj, Namrata
    Hamdani, Mohamed
    Ribeiro, Ramiro
    Rosenfeld, Philip J.
    Lad, Eleonora M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 227 : 116 - 124
  • [3] Predictive Identification of the Fastest Progressing Geographic Atrophy Lesions based on Deep Learning in the Phase 2 FILLY clinical trial of Pegcetacoplan
    Bogunovic, Hrvoje
    Lachinov, Dmitrii
    Mai, Julia
    Reiter, Gregor
    Riedl, Sophie
    Vogl, Wolf-Dieter
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [4] Clinical characteristics, progression and risk factors of geographic atrophy
    Brinkmann, C. K.
    Adrion, C.
    Mansmann, U.
    Schmitz-Valckenberg, S.
    Holz, F. G.
    OPHTHALMOLOGE, 2010, 107 (11): : 999 - 1006
  • [5] Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
    Wykoff, Charles C.
    Rosenfeld, Philip J.
    Waheed, Nadia K.
    Singh, Rishi P.
    Ronca, Nick
    Slakter, Jason S.
    Staurenghi, Giovanni
    Mones, Jordi
    Baumal, Caroline R.
    Saroj, Namrata
    Metlapally, Ravi
    Ribeiro, Ramiro
    OPHTHALMOLOGY, 2021, 128 (09) : 1325 - 1336
  • [6] PHASE-2 CLINICAL-TRIAL OF PREDNIMUSTINE
    不详
    BIOMEDICINE EXPRESS, 1977, 27 (04): : 158 - 161
  • [7] Comparison of Three Baseline Measures to Predict Geographic Atrophy Progression Rate in Clinical Studies
    Ho, Quoc
    Mackowski, Mia
    Kerr, Kevin
    Lopez, Francisco J.
    Schneider, Susan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [8] Topographic Effects on AI-Quantified Regional Progression in the FILLY Trial of Pegcetacoplan (APL-2) for Treatment of Geographic Atrophy Secondary to AMD
    Vogl, Wolf-Dieter
    Bogunovic, Hrvoje
    Mai, Julia
    Reiter, Gregor
    Riedl, Sophie
    Lachinov, Dmitrii
    Schmidt-Erfurth, Ursula
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [9] Impact of Baseline Quantitative Ellipsoid Zone Integrity on Geographic Atrophy Expansion in the ReCLAIM-2 Clinical Trial
    Whitmore, Victoria Eileen
    Kalra, Gagan
    Cetin, Hasan
    Whitney, Jon
    Yordi, Sari
    Cakir, Yavuz
    McConville, Conor Anthony
    Bonnay, Michelle
    Reese, Jamie
    Srivastava, Sunil K.
    Ehlers, Justis P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [10] Baseline Characterization of Advanced Ellipsoid Zone Integrity Features in the GATHER1 Phase 2/3 Clinical Trial for AMD with Geographic Atrophy
    Amine, Reem
    Yordi, Sari
    Cetin, Hasan
    McConville, Conor Anthony
    Kalra, Gagan
    Cakir, Yavuz
    Whitmore, Victoria Eileen
    Reese, Jamie
    Clark, Julie
    Zhu, Liansheng
    Srivastava, Sunil K.
    Ehlers, Justis P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345